Scott Rodig

21PUBLICATIONS

371CO-AUTHORS

Genome structure and regulationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Computational imagingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (21)

Sort by Publication Date:

|May 29, 2026

Author Correction: Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors.

|Mar 27, 2026

Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial.

Rebecca L Porter, Yinglu Zhou, Nebiyat Eskndir

|Mar 24, 2026

Same-Slide Spatial Multi-Omics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment.

Stephanie Pei Tung Yiu, Yuzhou Chang, Yao Yu Yeo

|Dec 20, 2025

Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors.

Vignesh Shanmugam, Neriman Tokcan, Daniel Chafamo

|Nov 20, 2025

Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors.

Kimberly J Perez, Nora Horick, Joanna Baginksa

|Nov 13, 2025

Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial.

Caron A Jacobson, Jason R Westin, David B Miklos

Pageof 4

Frequent Collaborators

Kathleen Pfaff

F Stephen Hodi

Margaret Shipp

Jason Weirather

Anita Giobbie-Hurder

Mark Magdi Awad

Michael P Manos

Biagio Ricciuti

Joanna Baginska

Alessandro Di Federico

Frequent Collaborators

Kathleen Pfaff

F Stephen Hodi

Margaret Shipp

Jason Weirather